These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28648755)

  • 1. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer.
    Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB
    Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
    Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
    Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12.
    Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y
    Clin Cancer Res; 2014 Mar; 20(6):1531-41. PubMed ID: 24449823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients.
    Huang C; Yu Z; Yang H; Lin Y
    Biomed Pharmacother; 2016 Oct; 83():8-13. PubMed ID: 27470544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
    Pang EJ; Yang R; Fu XB; Liu YF
    Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
    Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
    Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.
    Liu Y; Gao S; Du Q; Zhao Q
    Int J Mol Med; 2019 Jan; 43(1):547-556. PubMed ID: 30387807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
    Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of increased MALAT1 expression with pathological features and prognosis in cancer patients: a meta-analysis.
    Shi XS; Li J; Yang RH; Zhao GR; Zhou HP; Zeng WX; Zhou M
    Genet Mol Res; 2015 Dec; 14(4):18808-19. PubMed ID: 26782531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of long non-coding RNA MALAT1 for predicting the recurrence and metastasis of gallbladder cancer and its effect on cell proliferation, migration, invasion, and apoptosis.
    Sun KK; Hu PP; Xu F
    J Cell Biochem; 2018 Apr; 119(4):3099-3110. PubMed ID: 29058818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma.
    Gao KT; Lian D
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3561-5. PubMed ID: 27649655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
    Zhang S; Zhong G; He W; Yu H; Huang J; Lin T
    J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of long non‑coding RNA n346372 in bladder cancer tissues is associated with a poor prognosis.
    Liu A; Zhang Z; Xu W; Qin S; Hua M; Zeng S; Xu C
    Mol Med Rep; 2018 Dec; 18(6):5437-5444. PubMed ID: 30365104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 promoted invasiveness of gastric adenocarcinoma.
    Lee NK; Lee JH; Ivan C; Ling H; Zhang X; Park CH; Calin GA; Lee SK
    BMC Cancer; 2017 Jan; 17(1):46. PubMed ID: 28077118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA GHET1 promotes the development of bladder cancer.
    Li LJ; Zhu JL; Bao WS; Chen DK; Huang WW; Weng ZL
    Int J Clin Exp Pathol; 2014; 7(10):7196-205. PubMed ID: 25400817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
    Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.